Effects of long-term treatment with candesartan on organ damages in sinoaortic denervated rats

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 2, 2003, Pages 325-331

  Xie, He hui ^a   Miao, Chao Yu ^a   Liu, Jian Guo ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Baroreflex sensitivity; Blood pressure variability; Candesartan; End organ damage; Kidney; Sinoaortic denervation

Indexed keywords

ANGIOTENSIN; CANDESARTAN HEXETIL;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; AORTA HYPERTROPHY; AORTA SINUS DENERVATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DENERVATION; DRUG EFFECT; DRUG MECHANISM; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; KIDNEY INJURY; LONG TERM CARE; MALE; MULTIPLE REGRESSION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTECTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BENZIMIDAZOLES; DENERVATION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SINOATRIAL NODE; TETRAZOLES;

EID: 0037307815     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200302000-00023     Document Type: Article

References (25)

1. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Cir Res. 1983;53:96-104.
2. Su DF, Cerutti C, Barres C, Vincent M, Sassard J. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Physiol. 1986;251:H1111-7.
3. Miao CY, Shen FM, Su DF. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol Sin. 2001;22:137-40.
4. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol. 2001;28:709-15.
5. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-8.
6. Mancia G, Frattola A, Parati G, Santucciu C, Ulian L. Blood pressure variability and organ damage. J Cardiovasc Pharmacol. 1994;24(Suppl A):S6-11.
7. Shan ZZ, Dai SM, Su DF. Relationship between baroreceptor reflex function and end-organ damage in spontaneously hypertensive rats. Am J Physiol. 1999;277: H1200-6.
8. Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF. Aterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol. 2001;37:6-15.
9. Shan ZZ, Dai SM, Su DF. Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J Cardiovas Pharmacol. 2001;38:427-37.
10. Norman RA Jr, Coleman TG, Dent AC. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension. 1981;3:119-25.
11. 1-receptor blockers in isolated vessels of different origin. Hypertension. 1999;33:1406-13.
12. McConnaughey MM, McConnaughey JS, Ingenito AJ. Practical consideration of the pharmacology of angiotensin receptor blockers. J Clin Pharmacol. 1999;39:547-59.
13. McClellan KJ, Goa KL. Candesartan cilexetil: a review of its use in essential hypertension. Drugs. 1998;56:847-69.
14. Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaortic denervation-induced cardiovascular hypertrophy in rats. Acta Pharmacol Sin. 2002;23:713-20.
15. 1, receptor antagonism and protection against cardiovascular end-organ damage. J Human Hypertension. 1998;12:301-9.
16. Krieger EM. Neurogenic hypertension in the rat. Circ Res. 1964;XV:511-21.
17. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man: a quantitative method of assessing baroreflex sensitivity. Cir Res. 1969;24:109-21.
18. Su DF, Chen L, Kong XB, Cheng Y. Determination of arterial baroreflex-blood pressure control in conscious rats. Acta Pharmacol Sin. 2002;23:103-9.
19. Su DF, Cerutti C, Barres C, et al. Arterial baroreflex control of heart period is not related to blood pressure variability in conscious hypertensive and normotensive rats. Clin Exper Pharmacol Physiol. 1992;19:767-75.
20. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension. 1997;29:235-41.
21. Kimura K, Tojo A, Matsuoka H, Sugimoto T. Renel arteriolar diameters in spontaneously hypertensive rats: Vascular cast study. Hypertension. 1991;18:101-10.
22. Su DF, Miao CY. Arterial baroreflex function in conscious rats. Acta Pharmacol Sin. 2002;23:673-79.
23. Unger T, Culman J, Gohlke P. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence. J Hypertens. 1998;16(Suppl 7):S3-9.
24. Padilha JU, Krieger EM. Alteration in baroreceptor function in rats produces typical pressure changes during sleep. J Cardiovas Pharmacol. 1987;10 Suppl 12:S194-8.
25. 1, receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol. 1998;275:R1611-9.